Endocrine complications in thalassaemia major.
De Sanctis
V
V
Department of Paediatrics, Arcispedale S. Anna, Ferrara.
Vullo
C
C
Katz
M
M
Wonke
B
B
Hoffbrand
V A
VA
Di Palma
A
A
Bagni
B
B
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion; D003676:Deferoxamine / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology*; D005260:Female; D006801:Humans; D007006:Hypogonadism / Q000209:etiology*; D007011:Hypoparathyroidism / Q000209:etiology*; D007037:Hypothyroidism / Q000209:etiology*; D007502:Iron Chelating Agents / Q000627:therapeutic use; D008297:Male; D011628:Puberty, Delayed / Q000209:etiology*; D013789:Thalassemia / Q000150:complications* / Q000628:therapy
D007502:Iron Chelating Agents; D003676:Deferoxamine